BAX vs ENSG: fair value comparison
Baxter International Inc. and The Ensign Group, Inc. · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, BAX currently sits closer to the top of our discount ranking. ENSG carries the stronger quality grade.
| BAX | ENSG | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $23.80 | $173.20 |
| 12-month range | $16.78–$28.10 | $164.82–$215.67 |
| Sector rank | #54 of 113 Healthcare | #56 of 113 Healthcare |
| Quality grade | F | D |
| Leverage | High | Moderate |
| Margin trend | Contracting | Contracting |
| Revenue growth | Modest | Strong |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | — | Downtrend |
| DCF cross-check | Overvalued | Fairly Valued |
| 52-week position | The upper-middle quarter | The bottom quarter |
Full single-stock breakdowns: BAX fair value analysis · ENSG fair value analysis